rockyrai78908's blog

According to the latest report by IMARC Group, titled “Migraine Drugs Market Share: Global Industry Trends, Growth, Opportunity and Forecast 2022-2027”, The global migraine drugs market size reached US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2027, exhibiting a growth rate (CAGR) of 5.72% during 2022-2027. 


Migraine represents the neurological condition that causes unilateral or throbbing pain in the side of the head, forehead, and around the eyes. It is usually accompanied by autonomic symptoms, such as vomiting, nausea, photophobia, phonophobia, etc. Migraine is diagnosed by examining the medical history and symptoms of the patient and performing magnetic resonance imaging (MRI), blood tests, computerized tomography (CT) scans, etc. Presently, prescribed injections and over-the-counter (OTC) medicines are widely utilized to minimize the frequency as well as the severity of migraine attacks. They are either taken regularly or during exacerbations of chronic pain.


Global Migraine Drugs Market Trends:

The escalating demand for precision medicines is primarily driving the migraine drugs market. Additionally, the rising healthcare expenditure capacities of individuals and extensive improvement in reimbursement policies for migraine medications are further catalyzing market growth. Besides this, various types of migraine drugs, including ergot alkaloids, triptans, NSAIDs, acetylcholine inhibitors/ neurotoxins, ditans, CGRP mAbs, etc., are commonly available via hospital-based pharmacies, which is acting as another significant growth-inducing factor. Moreover, the development of product variants with novel mechanisms of action or new therapeutic targets and the inflating need for electrical nerve-stimulating devices to treat migraine are also positively influencing the global market. In line with this, the introduction of calcitonin gene-related peptide (CGRP) monoclonal antibodies that have higher clinical efficacy is anticipated to fuel the migraine drugs market over the forecasted period.

Request Free Sample Report: https://www.imarcgroup.com/migraine-drugs-market/requestsample

Global Migraine Drugs Market  2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • Allergan Plc (Abbvie Inc.)
  • Amgen Inc.
  • AstraZeneca Plc
  • Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
  • Eisai Co. Ltd.
  • Eli Lilly and Company
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA and Teva Pharmaceutical Industries Limited.

The report has segmented the market on the basis on region,  treatment type, drug type, route of administration and distribution channel.

Breakup by Treatment Type:

  • Abortive Treatment
  • Preventive Treatment 

Breakup by Drug Type:

  • Triptans
  • Ergot Alkaloids
  • NSAIDs
  • Acetylcholine Inhibitors/ Neurotoxins
  • Ditans
  • CGRP mAbs
  • Others

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Others 

Breakup by Distribution Channel:

  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2543&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Website: https://www.imarcgroup.com
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

According to the latest report by IMARC Group, titled, “Hormonal Contraceptive Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027″, The global hormonal contraceptive market size reached US$ 17.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 22.2 Billion by 2027, exhibiting a growth rate (CAGR) of 4.81% during 2022-2027.

Hormonal contraceptives refer to the formulations of progestin or a combination of estrogen and progesterone hormones. They work on the endocrine system to prevent ovulation and fertilization. As a result, hormonal contraceptives are utilized to avoid unwanted pregnancies and can be taken before and after vaginal intercourse. These formulations also affect the womb lining, which makes fertilized eggs difficult to be implanted. Such products include birth control pills, vaginal rings, contraceptive skin patches, hormone-releasing contraceptive coils, etc.

Hormonal Contraceptive Market Trends:

The growing awareness among consumers towards family planning is driving the hormonal contraceptive market. Moreover, the rising number of health issues associated with teenage pregnancies is further propelling the market growth. Besides this, various initiatives by government bodies and NGOs to support and enhance access to these products by promoting affordable and high-quality healthcare services are also augmenting the global market. Additionally, numerous advancements in the healthcare industry are leading the production of innovative products, such as hormonal patches, implants, intrauterine devices, etc., which are acting as significant growth-inducing factors. In the coming years, the increasing popularity of these devices owing to their several benefits, such as fewer side effects, high levels of efficiency in preventing pregnancy, ease of access, etc., is anticipated to fuel the global hormonal contraceptive market.

Request a Free Sample Reporthttps://www.imarcgroup.com/hormonal-contraceptive-market/requestsample

Hormonal Contraceptive Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Afaxys Inc.
  • Agile Therapeutics Inc.
  • Allergan Inc. (AbbVie Inc.)
  • Bayer AG
  • Cipla Limited
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Piramal Group
  • Teva Pharmaceutical Industries Ltd.

The report has segmented the market on the basis on product, hormone, age group and end user.

Breakup by Product:

  • Oral Contraceptive Pills
  • Intrauterine Device (IUD)
  • Injectable Birth Control
  • Vaginal Rings
  • Others

Breakup by Hormone:

  • Progestin-only Contraceptive
  • Combined Hormonal Contraceptive

Breakup by Age Group:

  • 15-24 Years
  • 25-34 Years
  • 35-44 Years
  • Above 44 Years

Breakup by End User:

  • Hospitals and Clinics
  • Homecare
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4403&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Website: https://www.imarcgroup.com
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

The latest research study “Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” Offers a comprehensive analysis of the industry, which comprises insights on the global biochips market share. The global biochips market size reached US$ 14.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 35.4 Billion by 2027, exhibiting a growth rate (CAGR) of 15.94% during 2022-2027.

Biochips Market Industry Definition and Application:

Biochips are miniature versions of a laboratory designed for functioning in a biological environment, especially inside living organisms. They contain millions of sensor elements or biosensors that act as microreactors to detect a particular analyte like a protein, DNA, enzyme, or antibody. They can perform thousands of biological reactions in a few seconds for drug discovery, single nucleotide polymorphism genotyping, in-vitro diagnostics, gene expression profiling and agricultural biotechnology.

Download free sample of the report: https://www.imarcgroup.com/biochips-market/requestsample

Biochips Market Trends and Drivers:

The global biochips market is primarily driven by growing investments in the healthcare sector. The onset of the coronavirus disease (COVID-19) pandemic has encouraged several biotechnology and pharmaceutical companies to develop biochips for detecting viral infections and immunological disorders in the human body. Besides this, these chips are widely used in the medical industry to detect cancerous cells in the body and for forming targeted and personalized medicines for cancer treatment. Moreover, several advancements and upgradation in nanotechnology and extensive research and development (R&D) activities that results in the emergence of digital microfluidic biochips are also providing a positive thrust to the market growth.

Biochips Market Segmentation:

The report has segmented the market on the basis on type, application, technology, materials, distribution channel and end user.

 

Breakup by Product Type:

  • DNA Chip
  • Protein Chip
  • Lab-On-a-Chip
  • Enzyme Chip

Breakup by Fabrication Technique:

  • Microarray
  • Microfluidic

Breakup by Analysis Method:

  • Electrophoresis
  • Luminescence
  • Mass Spectrometry
  • Electrical Signals
  • Magnetism

Breakup by Application:

  • Molecular Analysis
    • Hybridization
    • Protein
    • Immunological
    • Biomolecules
    • Biomarker
    • Others
  • Diagnosis
    • Gene Diagnosis
    • Oncology
    • Inflammatory
    • Others
  • Non-Biological Usage

Breakup by End User:

    • Pharmaceutical and Biotechnology Companies
    • Hospitals and Diagnostics Centers
    • Academic & Research Institutes
    • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the Major Biochips Market Key players?

The report provides a detailed analysis of the market leaders, including.

  • Agilent Technologies, Inc.
  • bioMérieux SA
  • Bio-RAD Laboratories, Inc.
  • CapitalBio Corporation
  • Dynamic Biosensors GmbH
  • EMD Millipore Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Thermo Fisher Scientific Inc.

 

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2741&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Website: https://www.imarcgroup.com
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

According to the latest report by IMARC Group, titled, “Glycolic Acid Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, Offers a comprehensive analysis of the industry, which comprises insights on the global glycolic acid market size. The global glycolic acid market reached a value of US$ 398 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 599 Million by 2027, exhibiting a CAGR of 7.28% during 2022-2027. 

Glycolic acid (C2H4O3) stands for an alpha hydroxy acid (AHA) that is derived from various plants, including grapes, sugar beets, pineapple, etc. It is colorless, odorless, soluble in water, non-volatile, etc. Glycolic acid is commonly utilized as an exfoliant in skincare products, such as cleansers, moisturizers, serums, face masks, etc., to prevent acne, fade hyperpigmentation, remove dead skin cells, etc. It is used in leather tanning, textile and metal processing, fabric dyeing, printing, etc. Apart from this, it also finds applications as an etching agent in oil well operations.

Glycolic Acid Market Trends:

The increasing influence of social media, inflating income levels, and growing focus on physical appearances are driving the demand for skin care products, which is primarily augmenting the glycolic acid market. Moreover, glycolic acid is also utilized in the food and beverage (F&B) industry as a preservative, flavoring agent, and adhesive for packaging products. In addition to this, increasing environmental concerns are encouraging the manufacturing of economic and biodegradable cleaning products, which utilize glycolic acid. Additionally, several key manufacturers are investing in research and development (R&D) activities to improve product efficacy and effectiveness. Furthermore, the rising usage of glycolic acid in the production of biomedical devices, such as staples, sutures, implants, meshes, etc., is expected to fuel the global glycolic acid market in the coming years.

Request a Free Sample Reporthttps://www.imarcgroup.com/glycolic-acid-market/requestsample

Glycolic Acid Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Avid Organics
  • CABB Group GmbH
  • China Petrochemical Corporation
  • CrossChem Limited
  • Mehul Dye Chem Industries
  • Merck KGaA
  • Parchem fine and specialty chemicals
  • The Chemours Company
  • Tokyo Chemical Industry Co. Ltd
  • Water Chemical Co. Ltd
  • Zhonglan Industry Co. Ltd

The report has segmented the market on the basis on source, purity level and application.

Breakup by Source:

  • Synthetic
  • Natural

Breakup by Purity Level:

  • 99% Purity
  • 70% Purity
  • 60% Purity
  • 30% Purity
  • Others

Breakup by Application:

  • Personal Care and Cosmetics
  • Household
  • Textile
  • Food Processing
  • Pharmaceuticals
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4464&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA 
Website: https://www.imarcgroup.com
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

According to the latest report by IMARC Group, titled “Commercial Seaweeds Market: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” The global commercial seaweeds market reached a value of US$ 17.7 Billion 2021. Looking forward, IMARC Group expects the market to reach US$ 31.0 Billion by 2027, exhibiting a CAGR of 9.71% during 2022-2027.


Commercial seaweeds refer to macroalgae attached to hard substrata in lakes, rivers, oceans, and several other water bodies. They are extensively used to produce water-soluble carbohydrates, which further find widespread applications in the food and beverage sector to increase the viscosity of aqueous solutions. They also help in enhancing the skin moisture retention properties of cosmetic products, such as lotions and creams. Moreover, due to the rich fiber content, commercial seaweeds are used as a soil conditioner and can be watered or applied directly around the plant root areas.


Commercial Seaweeds Market Trends:

The increasing consumption of seaweed as dietary supplements is primarily driving market growth. Furthermore, seaweeds are rich in bioactive compounds and have antimicrobial and antioxidant properties, which make them suitable for several medicinal purposes. Moreover, the expanding food and beverage (F&B) industry is increasingly adopting commercial seaweeds to stabilize ice creams, form gels, and produce water-soluble films. Additionally, the growing application of commercial seaweed as a thickening agent in the textile industry is also catalyzing the product demand. Besides this, as seaweeds can absorb heavy metal ions, like cadmium and zinc, from polluted water, they are gaining widespread traction in wastewater treatment plants across the globe. This is anticipated to further propel the global commercial seaweed market in the coming years.

Request Free Sample Report: https://www.imarcgroup.com/commercial-seaweeds-market/requestsample

Global Commercial Seaweeds Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Acadian Seaplants Limited
  • Algaia SA (Maabarot Products Ltd.)
  • Biostadt India Limited
  • BrandT Consolidated Inc.
  • Cargill Incorporated
  • COMPO Expert GmbH
  • CP Kelco U.S. Inc. (J.M. Huber Corporation)
  • DuPont de Nemours Inc.
  • Gelymar S.A.
  • Indigrow Ltd.
  • Lonza Group AG
  • Seasol International Pty. Ltd.
  • TBK Manufacturing Corporation.

The report has segmented the market on the basis on on region, product, form and application.

Breakup by Product:

  • Brown Seaweeds
  • Red Seaweeds
  • Green Seaweeds

Breakup by Form:

  • Liquid
  • Powdered
  • Flakes

Breakup by Application:

  • Agriculture
  • Animal Feed
  • Human Consumption
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3336&flag=C

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

According to the latest report by IMARC Group, titled, “Electric Truck Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028″, The global electric truck market size reached US$ 515.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,556.1 Million by 2028, exhibiting a growth rate (CAGR) of 32.2% during 2023-2028.

An electric truck refers to a commercial vehicle operating on rechargeable batteries for transporting cargo. It is reliable and cost-effective,minimizes carbon emission and vehicular noise, and equipped with regenerative braking systems and automatic start and stop facilities. It is manufactured using lightweight materials and widely available in hybrid variants that operate via both fuel-gas and battery-operated engines.

Electric Truck Market Trends

Rapid urbanization, burgeoning automotive industry, and rising consumer preferences for hybrid and electric vehicles (H/EVs)are among the major factors positively influencing the market. In addition to this, governing authorities of numerous countries are undertaking initiatives to encourage the adoption of electric trucks, minimize the consumption of fossil fuels and consequently reduce greenhouse (GHG) emissions, which is bolstering the growth of the market. Furthermore, various technological advancements, including enhancements in the electronic charging infrastructure and the usage of magnetic resonance for wireless vehicle charging, are other factors anticipated to drive the market.

Request Free Sample Reporthttps://www.imarcgroup.com/electric-truck-market/requestsample

Global Electric Truck 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • AB Volvo
  • BYD Company Ltd.
  • Daimler AG
  • FAW Group Co. Ltd.
  • Navistar Inc.
  • PACCAR Inc.
  • Rivian Automotive Inc.
  • Scania AB (Volkswagen AG)
  • Tata Motors Limited
  • Tesla Inc.
  • Tevva Motors Limited

The report has segmented the market on the based on region, vehicle type, propulsion, range and application.

Breakup by Vehicle Type:

  • Light-duty Truck

  • Medium-duty Truck

  • Heavy-duty Truck

Breakup by Propulsion:

  • Battery Electric Truck

  • Hybrid Electric Truck

  • Plug-in Hybrid Electric Truck

  • Fuel Cell Electric Truck

Breakup by Range:

  • 0-150 Miles

  • 151-300 Miles

  • Above 300 Miles

Breakup by Application:

  • Logistics

  • Municipal

  • Construction

  • Mining

  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3635&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

According to IMARC Group’s latest report, titled “Medical Foods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” The global medical foods market reached a value of US$ 20.69 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.18 Billion by 2027, exhibiting a CAGR of 5.80% during 2022-2027.

Industry Definition and Application:

Medical foods are intended for the dietary management of a disease, which cannot be met through a normal diet alone. They are prepared for the partial or exclusive feeding of the patient through oral intake or enteral feeding by tube under the supervision of a medical specialist. They are formulated under the supervision of a physician according to scientific principles and medical evaluation. They are composed of food additives, color additives, and a combination of vitamins, minerals, and botanicals for better dietary management. Medical foods support the therapeutic effects of the drug and offer an effective therapeutic tool for managing pain, sleep, and cognitive disorders. Presently, they are available in pills, liquid, and powder forms across the globe.

Download free sample brochure: https://www.imarcgroup.com/medical-foods-market/requestsample

Global Medical Foods Market Industry Trends and Drivers: 

At present, the growing global geriatric population and increasing cases of medical ailments, such as cancer, attention-deficit or hyperactivity disorder (ADHD), depression, diabetes, cancer, and Alzheimer’s,  represent one of the key factors positively influencing the market. In line with this, the rising prevalence of metabolic and gastrointestinal diseases due to sedentary lifestyles is catalyzing the demand for medical foods. Moreover, the development in the healthcare sector and the introduction of favorable initiatives for the manufacturing of medical foods to meet the specific requirement of patients are currently bolstering the growth of the market. Additionally, the easy availability of medical foods in grocery stores and pharmacies is creating a positive market outlook. In line with this, rapid digitization, increasing sales of smartphones, and the rising penetration of high-speed internet are contributing to the increasing sales of medical foods through e-commerce platforms.

Moreover, the widespread adoption of natural sources, bioactive compounds, and food rich in phytochemicals for manufacturing medical foods is supporting the market growth. Besides this, as medical foods aid in boosting the immune and digestive systems of individuals, they are gaining immense traction across the globe. Furthermore, inflating income levels and changing dietary patterns worldwide are creating a favorable market outlook. Additionally, stringent government guidelines are encouraging investors in efficient production and effective maintenance of the product. Specific emphasis on nutritional requirements adhering to clinical guidelines is positively influencing the market. Apart from this, the growing research and development (RD) activities to offer novel medical food products, fulfill the nutritional demand of consumers, and enhance the shelf-life of food items without compromising on their taste and nutritional values are anticipated to drive the market in the coming years.

Report Segmentation:

The report has been segmented the market into following categories:

Product Insights:

  • Pills
  • Powder
  • Others

Route of Administration Insights:

  • Oral
  • Enteral

Application Insights:

  • ADHD
  • Depression
  • Diabetes
  • Cancer
  • Alzheimer's Disease
  • Metabolic Disorders
  • Others

Distribution Channel Insights:

  • Supermarkets
  • Hospital and Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

List of Major Key Players:

  • Abbott Healthcare Private Limited (NSE: ABBOTINDIA)
  • Alfasigma S.p.A
  • Danone S.A (EPA: BN)
  • Fresenius Kabi AG (ETR: FRE)
  • Mead Johnson Company
  • Medtrition Inc
  • Meiji Holdings Co., Ltd (TYO: 2269)
  • Metagenics
  • Inc.
  • Nestlé S.A
  • Primus Pharmaceuticals, Inc
  • Targeted Medical Pharma Inc
  • Victus, Inc

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3637&flag=C

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
Email: [email protected]
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Linkedin: https://www.linkedin.com/company/imarc-group

According to the latest report by IMARC Group, titled “Automotive Thermal System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global automotive thermal system market size reached US$ 34.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 43.8 Billion by 2027, exhibiting a growth rate (CAGR) of 4.17% during 2022-2027.

Automotive thermal systems monitor and regulate the working temperatures of numerous automobile components, including motors, batteries, the cabinet area, etc., to increase their efficiency, prevent a breakdown, reduce temperature fluctuations, etc. They usually comprise of compressors, fluid transport, heating, ventilation, and air conditioning (HVAC) systems, powertrain cooling mechanisms, etc. Automotive thermal systems also decrease fuel consumption and improve powertrain efficacy, which controls carbon emissions. They are extensively utilized to manufacture heavy vehicles across the transportation and construction industries.

Global Automotive Thermal System Market:

The escalating need to minimize the carbon emissions produced by internal combustion engines (ICEs) and the implementation of stringent regulations by government bodies to reduce vehicular pollution are primarily driving the automotive thermal system market. Moreover, the increasing adoption of advanced and sustainable HVAC systems is further catalyzing market growth. Besides this, the rising popularity of electric vehicles (EVs) is acting as another significant growth-inducing factor, owing to the utilization of automotive thermal systems to maintain battery temperature at optimum operating conditions and enhance user comfort without impacting vehicle efficiency. Furthermore, the integration of these systems with sensors that sense the temperature in real-time is augmenting the global market. Apart from this, the growing number of construction activities across countries is propelling the demand for heavy vehicles, which, in turn, is expected to stimulate the automotive thermal system market over the forecasted period.

Request Free Sample Reporthttps://www.imarcgroup.com/automotive-thermal-system-market/requestsample

Global Automotive Thermal System Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

  • Borgwarner Inc.
  • Continental Aktiengesellschaft
  • DENSO Corporation
  • General Motors Company
  • Gentherm Incorporated
  • Grayson Automotive Services Limited
  • Lennox International Inc.
  • MAHLE GmbH
  • Modine Manufacturing Company Inc.
  • Visteon Corporation.

The report has segmented the market on the basis of region, component and vehicle type.

Breakup by Component:

  • Compressor
  • HVAC
  • Powertrain Cooling
  • Fluid Transport

Breakup by Vehicle Type:

  • Passenger Cars
  • Light Commercial Vehicles
  • Heavy Commercial Vehicles
  • Others

Breakup by Region:

  • North America:( United States, Canada)
  • Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2768&flag=C

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size, and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

The latest research study “Cryptocurrency Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” The global cryptocurrency market size reached US$ 1,782 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32,420 Billion by 2027, exhibiting a growth rate (CAGR) of 58.4% during 2022-2027.


Global Cryptocurrency Industry Definition and Application:

Cryptocurrency also called a crypto coin, represents a digital or virtual currency encrypted by cryptography to monitor transactions and prevent counterfeiting or double-spend. It operates via decentralized networks based on blockchain technology and can be distributed over computer networks connected to a virtual environment. Cryptocurrency ensures enhanced safety and eliminates the risk of identity theft as it involves using authenticated security passwords linked directly to the digital wallet of users. Presently, it is widely preferred over traditional currencies as cryptocurrency facilitates quicker payments with zero transaction charges and offers inflation resistance and transparency.


Request Free Sample Report: https://www.imarcgroup.com/cryptocurrency-market/requestsample

Cryptocurrency Market Trends and Drivers: 

The inflating need for operational efficiency, security, and transparency in financial payment systems is primarily augmenting the cryptocurrency market. Furthermore, the increasing penetration of high-speed internet and the growing installation of trading applications on smartphones that offer seamless access to online payment transactions are acting as significant growth-inducing factors. Apart from this, legalization and approval of the sale, purchase, trade, etc., of cryptocurrencies, including bitcoin, ripple, Ethereum, etc., in numerous countries, and extensive R&D activities are also positively influencing the global market.


Moreover, the rising prevalence of fraudulent and undesirable transactions, on account of manual or machine errors and data manipulation, is bolstering the market growth. Besides this, the introduction of blockchain or distributed ledger technology that offers transparency, tracks any modifications in real-time, enhances data security and transaction immutability, etc., is further catalyzing the global market. Additionally, the escalating demand for contactless payments is expected to fuel the cryptocurrency market in the coming years.


Cryptocurrency Market Segmentation 2022-27:

The report has been segmented the market into following categories:

Type Insights:

  • Bitcoin
  • Ethereum
  • Bitcoin Cash
  • Ripple
  • Litecoin
  • Dashcoin
  • Others

Component Insights:

  • Hardware
  • Software

Process Insights:

  • Mining
  • Transaction

Application Insights:

  • Trading
  • Remittance
  • Payment
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

List of Major Key Players:

  • Advanced Micro Devices Inc.
  • Alphapoint Corporation
  • Bitfury Holding B.V.
  • Coinbase Inc.
  • Cryptomove Inc.
  • Intel Corporation
  • Microsoft Corporation
  • Quantstamp, Inc.
  • Ripple Services Inc.

Ask Analyst and Browse Full Report with TOC & List of Figure:  https://www.imarcgroup.com/request?type=report&id=2546&flag=C


Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.


IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.


Contact Us

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

According to the latest report by IMARC Group, titled “Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global autoimmune disease diagnosis market size reached US$ 3.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2027, exhibiting a growth rate (CAGR) of 6.4% during 2022-2027.

An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition.

Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample

Global Autoimmune Disease Diagnosis Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • AESKU.GROUP
  • Danaher Corp.
  • bioMérieux SA
  • Bio-Rad Laboratories
  • PerkinElmer Inc.
  • Hemagen Diagnostics, Inc.
  • Inova Diagnostics, Inc.
  • Myriad Genetics, Inc.
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • SQI Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc.

The report has segmented the market on the basis of product, disease, test, user and Region

Breakup by Product Type:

  • Consumables and Assay Kits
  • Instruments

Breakup by Disease Type:

  • Systemic Autoimmune Disease
  • Localized Autoimmune Disease

Breakup by Test Type:

  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies and Immunologic Tests
  • Others

Breakup by End-User:

  • Clinical Laboratories
  • Hospitals
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2250&flag=C

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Pages: 1 2 »